Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like Servo2Go introduces EXOR eX700 series of HMIs November 25, 2019 Balluff introduces ceramic caps for sensors July 28, 2018 Otis announces Otis ONE IoT service platform for elevators and escalators May 21, 2018